IRIS
VENA, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.084
Totale 6.084
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 6.084
Totale 6.084
Salva come PNG Salva come JPEG
Città #
Genova 2.105
Genoa 1.562
Rapallo 1.209
Vado Ligure 1.131
Bordighera 77
Totale 6.084
Salva come PNG Salva come JPEG
Nome #
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 167
Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study 132
Incidence and outcome of invasive candidiasis in intensive care units (icus) in europe: Results of the eucandicu project 120
Treatment of Infections Due to MDR Gram-Negative Bacteria 115
A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality 101
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study 97
Coagulative Disorders in Critically Ill COVID-19 Patients with Acute Distress Respiratory Syndrome: A Critical Review 91
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy 91
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 89
External validation of unsupervised COVID-19 clinical phenotypes and their prognostic impact 88
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 86
Bloodstream infections in critically ill patients with COVID-19 85
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy 78
A brief note on randomized controlled trials and compassionate/off-label use of drugs in the early phases of the COVID-19 pandemic 77
Invasive Candida Infections in Liver Transplant Recipients: Clinical Features and Risk Factors for Mortality 77
Association between source control and mortality in 258 patients with intra-abdominal candidiasis: a retrospective multi-centric analysis comparing intensive care versus surgical wards in Spain 75
The role of new β-lactamase inhibitors in gram-negative infections 73
Early Detection of Sepsis With Machine Learning Techniques: A Brief Clinical Perspective 72
Prevalence of Antibodies to SARS-CoV-2 in Italian Adults and Associated Risk Factors 71
Computed tomography assessment of PEEP-induced alveolar recruitment in patients with severe COVID-19 pneumonia 69
Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors 69
Diagnosis and Treatment of Candidemia in the Intensive Care Unit 68
Chest physiotherapy: An important adjuvant in critically ill mechanically ventilated patients with COVID-19 68
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia 67
Distinct phenotypes require distinct respiratory management strategies in severe COVID-19 65
New antibiotics for ventilator-associated pneumonia 63
Risk factors for candidemia after open-heart surgery: results from a multicenter case-control study 62
Challenges and Solution of Invasive Aspergillosis in Non-neutropenic Patients: A Review 62
Emerging treatment options for acute bacterial skin and skin structure infections: Focus on intravenous delafloxacin 62
Isavuconazole shortens the QTc interval 61
Management of patients with septic shock due to Candida infection 59
How to manage Pseudomonas aeruginosa infections 57
Validation of an Automated System for the Extraction of a Wide Dataset for Clinical Studies Aimed at Improving the Early Diagnosis of Candidemia 56
Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG 56
Risk stratification and treatment of ICU-acquired pneumonia caused by multidrug-resistant/ extensively drug-resistant/pandrug-resistant bacteria 56
Early effects of ventilatory rescue therapies on systemic and cerebral oxygenation in mechanically ventilated COVID-19 patients with acute respiratory distress syndrome: a prospective observational study 56
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 56
Lung distribution of gas and blood volume in critically ill COVID-19 patients: a quantitative dual-energy computed tomography study 55
Tracheostomy Timing and Outcome in Severe COVID-19: The WeanTrach Multicenter Study 55
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 54
Neurological Complications and Noninvasive Multimodal Neuromonitoring in Critically Ill Mechanically Ventilated COVID-19 Patients 53
Antibiotic treatment of acute bacterial skin and skin structure infections 50
Spread of carbapenem-resistant gram-negatives and candida auris during the covid-19 pandemic in critically ill patients: One step back in antimicrobial stewardship? 49
null 49
Characterization of T lymphocytes in severe COVID-19 patients 49
Early administration of bamlanivimab in combination with etesevimab increases the benefits of covid-19 treatment: Real-world experience from the liguria region 49
The novel Chinese coronavirus (2019-nCoV) infections: Challenges for fighting the storm 48
A comparative analysis of the first and second COVID-19 wave in Italy: evaluation of mortality in the Infectious Disease Unit of Genoa University Hospital 48
Clinical Experience with Ceftazidime-Avibactam for the Treatment of Infections due to Multidrug-Resistant Gram-Negative Bacteria Other than Carbapenem-Resistant Enterobacterales 47
Clinical efficacy of eucaloric ketogenic nutrition in the COVID-19 cytokine storm: A retrospective analysis of mortality and intensive care unit admission 47
Rational approach in the management of Pseudomonas aeruginosa infections 46
Treatment of severe infections due to metallo-β-lactamases-producing Gram-negative bacteria 46
High doses of hydroxychloroquine do not affect viral clearance in patients with SARS-CoV-2 infection 46
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study) 45
Reply to: “Antiviral Activity and Safety of Darunavir/Cobicistat for Treatment of COVID-19” 45
Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience 44
A Response to: Letter to the Editor Regarding Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP) 44
Higher mortality and intensive care unit admissions in COVID-19 patients with liver enzyme elevations 43
Bezlotoxumab for Preventing Recurrent Clostridioides difficile Infection: A Narrative Review from Pathophysiology to Clinical Studies 43
Early Effects of Passive Leg-Raising Test, Fluid Challenge, and Norepinephrine on Cerebral Autoregulation and Oxygenation in COVID-19 Critically Ill Patients 42
The multifaceted presentation of syphilitic chorioretinitis examined by multimodal imaging: A case series 41
The Role of Dysbiosis in Critically Ill Patients With COVID-19 and Acute Respiratory Distress Syndrome 41
Antifungal susceptibility testing in Candida, Aspergillus and Cryptococcus infections: are the MICs useful for clinicians? 40
Treatment of Bloodstream Infections Due to Gram-Negative Bacteria with Difficult-to-Treat Resistance 39
Molecular epidemiological investigation of a nosocomial cluster of c. Auris: Evidence of recent emergence in italy and ease of transmission during the covid‐19 pandemic 38
Adequate duration of therapy in severe fungal infections 38
Challenges and research priorities to progress the impact of antimicrobial stewardship 37
COVID-19: Some clinical questions after the first 4 months 37
Intermediate monocytes expansion and homing markers expression in COVID-19 patients associate with kidney dysfunction 36
Short Course of Antifungal Therapy in Patients With Uncomplicated Candida Bloodstream Infection: Another Case of Less Is More in the Clinical Setting? 36
Is a step-down antiretroviral therapy necessary to fight severe acute respiratory syndrome coronavirus 2 in HIV-infected patients? 36
Recent molecules in the treatment of severe infections caused by ESBL-producing bacteria 36
Therapeutic options for difficult-to-treat Acinetobacter baumannii infections: a 2020 perspective 36
Antiviral treatment selection for SARS-CoV-2 pneumonia 36
Role or oritavancin and dalbavancin in acute bacterial skin and skin structure infections and other potential indications 35
Reuse of clinical COVID-19 patient data: Pre-processing for future classification 34
Early versus late intubation in COVID-19 patients failing helmet CPAP: A quantitative computed tomography study 34
Aspergillus-PCR in bronchoalveolar lavage - diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients 33
Risk Factors for Intra-Abdominal Candidiasis in Intensive Care Units: Results from EUCANDICU Study 33
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 32
Neurological Manifestations of Severe SARS-CoV-2 Infection: Potential Mechanisms and Implications of Individualized Mechanical Ventilation Settings 32
Mould Infections of Traumatic Wounds: A Brief Narrative Review 32
Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, adult patients: A systematic review with qualitative evidence synthesis 32
Frequency of Detection of Candida auris Colonization Outside a Highly Endemic Setting: What Is the Optimal Strategy for Screening of Carriage? 31
Ceftaroline for severe community-acquired pneumonia: A real-world two-centre experience in Italy and Spain 31
Sensitivity of Serum Beta-D-Glucan in Candidemia According to Candida Species Epidemiology in Critically Ill Patients Admitted to the Intensive Care Unit 29
Aspergillus endocarditis in the recent years, report of cases of a multicentric national cohort and literature review 28
An evidence-based bundle improves the quality of care and outcomes of patients with candidaemia 28
Triple combination therapy with two antivirals and monoclonal antibodies for persistent or relapsed SARS-CoV-2 infection in immunocompromised patients 27
Prevalence of Viral Hepatitis in Unselected, Consecutively Enrolled Patients Hospitalised for SARS-CoV-2 26
Early Clinical Experience with Molnupiravir for Mild to Moderate Breakthrough COVID-19 among Fully Vaccinated Patients at Risk for Disease Progression 26
Healthcare Worker Study Cohort to Determine the Level and Durability of Cellular and Humoral Immune Responses after Two Doses of SARS-CoV-2 Vaccination 26
Barriers to HCV micro-elimination in a cohort of people living with HIV (PLWH) 26
Outcome of early treatment of SARS-CoV-2 infection in patients with haematological disorders 26
Clinical efficacy of ceftolozane-tazobactam versus other active agents for the treatment of bacteremia and nosocomial pneumonia due to drug-resistant pseudomonas aeruginosa 26
Mortality in KPC-producing Klebsiella pneumoniae bloodstream infections: a changing landscape 25
Antifungal stewardship in daily practice and health economic implications 25
Balancing evidence and frontline experience in the early phases of the COVID-19 pandemic: current position of the Italian Society of Anti-infective Therapy (SITA) and the Italian Society of Pulmonology (SIP) 24
Clinical presentation of secondary infectious complications in COVID-19 patients in intensive care unit treated with tocilizumab or standard of care 24
Levels of beta-D-glucan in Candida auris supernatants, an in vitro and in vivo preliminary study 24
Totale 5.270
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.070
article - articoli 40.070
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.140
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020535 0 0 0 0 31 53 115 72 87 99 53 25
2020/2021682 15 45 67 39 40 41 80 67 73 98 70 47
2021/2022963 37 28 37 63 48 40 48 168 184 94 58 158
2022/20231.510 117 135 15 137 172 155 80 96 243 122 184 54
2023/20241.371 57 108 35 173 139 215 126 128 66 50 90 184
2024/20251.220 107 283 105 234 491 0 0 0 0 0 0 0
Totale 6.382